Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin
about
The treatment of infections in general practice with magnapen: a multicentre trialHLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics.Flucloxacillin in bone.Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infectionsPharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapenSingle-dose pharmacokinetics of dicloxacillin in healthy subjects of young and old age.Concentrations of flucloxacillin in heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgeryFlucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial.A retrospective comparison of ceftriaxone versus oxacillin for osteoarticular infections due to methicillin-susceptible Staphylococcus aureusAssessing the Surrogate Susceptibility of Oxacillin and Cefoxitin for Commonly Utilized Parenteral Agents against Methicillin-Susceptible Staphylococcus aureus: Focus on Ceftriaxone Discordance between Predictive Susceptibility and in Vivo ExposuresSafety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.Absorption of orally administered nafcillin in normal healthy volunteersThe use of antimicrobial drugs in office practice.Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.A mixed methods study of the administration of flucloxacillin oral liquid; identifying strategies to overcome administration issues of medicines with poor palatability.Comparative Effectiveness of Cefazolin versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.Plasma and tissue protein binding of drugs in pharmacokinetics.A method for studying antibiotic concentrations in inflammatory exudate.Organocatalytic one-pot 1,4-/1,6-/1,2-addition sequence for the stereocontrolled formation of six consecutive stereocenters.Removal of antibiotic cloxacillin by means of electrochemical oxidation, TiO2 photocatalysis, and photo-Fenton processes: analysis of degradation pathways and effect of the water matrix on the elimination of antimicrobial activity.Rationale for eliminating Staphylococcus breakpoints for β-lactam agents other than penicillin, oxacillin or cefoxitin, and ceftaroline.Predicted Biological Activity of Purchasable Chemical Space.Removal of β-lactam antibiotics from pharmaceutical wastewaters using photo-Fenton process at near-neutral pH.Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.Choice among penicillins and cephalosporins.Evaluation of Triazole and Isoxazole Derivatives as Potential Anti-infective AgentsSuccessful Debridement of a Knee Joint Prosthesis Infected with . Case Report and Review of Current Literature
P2860
Q28283181-DC6BBD6F-B41E-4EAF-8A92-74DAAF7838CCQ29417159-F208F4A8-8C0D-4D12-A919-3BD59CEDA9BFQ31804274-088DD375-D587-42E5-845B-F2B44F4702D4Q33846477-A02656B0-33FA-490A-A816-CB1B6A76F905Q33978627-AEA8ACF2-5D11-4D55-8443-F75E0C522209Q34451547-CFE6693A-FCD1-4D3C-941E-F53794BB1528Q34516758-F9DA4E31-A007-44BD-9575-E7B14FB4BB92Q34692191-02EC8D60-B7F9-4C65-8507-58A4F390ACA5Q35310537-3E6957E7-2EAC-474E-B931-59C6F62EC0EFQ35347028-D9A47A28-8C3F-4A58-8FAA-80929E6F5F86Q35745670-B08D8D60-66EB-46AB-A7DE-2F52FF9B460EQ36096382-D1FC8442-E1B4-4E50-A6D5-1957637E4588Q36208386-DBE82635-4899-4440-A245-037C6C8EC6D1Q36463721-E40C8D46-5C51-4B61-A76A-7F8EB503E620Q36553608-015A5CBA-6C69-4273-971E-B7FC5AEBE5A5Q37203845-8A21A866-9040-4980-A5EC-03B8E34E45A6Q38955482-B66191F3-6146-4F60-AFA3-8AA29AFEFD6AQ40257163-ACBD0336-5845-4996-867F-72ADE8D8B37BQ40809296-129AF53F-7EC2-43E6-91FC-5DFAFBDADFC2Q41254966-4D79E81D-8A0C-4E17-84E8-965D36E7524EQ43107349-7076A798-EA8E-4726-9D78-0D8745FA3B53Q43345511-CA4C44DD-84B5-4AD1-9AF7-6EA5DFD2549AQ44566052-0E954EB4-0962-4E75-9B1F-90D329335B83Q47385721-3F12B7A9-C99A-495F-97BD-125026E85DBFQ50912291-D38443F7-496C-4D40-9CA7-64692524A4EDQ53879693-FC507715-D096-44E9-8B3F-D9C960EF5C3AQ55380101-105CBEA3-3390-4EF8-B5C5-16DC6956D890Q58131623-0C247D90-3742-4BF7-9009-425910B57886Q58699454-4D457DFA-F21A-42C7-9892-BFE8E993A226
P2860
Flucloxacillin, a new isoxazolyl penicillin, compared with oxacillin, cloxacillin, and dicloxacillin
description
1970 nî lūn-bûn
@nan
1970 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1970 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1970年の論文
@ja
1970年論文
@yue
1970年論文
@zh-hant
1970年論文
@zh-hk
1970年論文
@zh-mo
1970年論文
@zh-tw
1970年论文
@wuu
name
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@ast
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@en
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@nl
type
label
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@ast
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@en
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@nl
prefLabel
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@ast
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@en
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@nl
P2093
P2860
P356
P1433
P1476
Flucloxacillin, a new isoxazol ...... cloxacillin, and dicloxacillin
@en
P2093
E A Croydon
G N Rolinson
R Sutherland
P2860
P304
P356
10.1136/BMJ.4.5733.455
P407
P577
1970-11-21T00:00:00Z